about
How Do You Use AAPS PharmSciTech?Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing.Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.Formation of stable submicron protein particles by thin film freezing.In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.Inhaled nanoparticles--a current review.Encapsulation of protein nanoparticles into uniform-sized microspheres formed in a spinning oil film.Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.Influence of particle size on regional lung deposition--what evidence is there?Has nanotechnology led to improved therapeutic outcomes?The impact of pulmonary diseases on the fate of inhaled medicines--a review.Hot-melt extrusion--basic principles and pharmaceutical applications.Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A ReviewThermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2)A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing.Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers.Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats.Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model.Long-term stability of heat-humidity cured cellulose acetate phthalate coated beads.Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole.A novel particle engineering technology: spray-freezing into liquid.Enhanced drug dissolution using evaporative precipitation into aqueous solution.Properties of heat-humidity cured cellulose acetate phthalate free films.Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology.A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid.Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam.Nebulization of mycophenolate mofetil inhalation suspension in rats: comparison with oral and pulmonary administration of Cellcept®.Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties.
P50
Q27638352-078EF4D7-9FAE-428F-A352-BE46A6AC24E4Q31043970-F53CA601-8E9F-4E44-BE14-5BE367A9E623Q33260113-C074243F-FAD1-438C-8BAD-F221E1628120Q33320560-1B0B78C4-B7A9-4119-BDBE-21407C873B71Q33962560-EADCC148-A577-4D5B-A399-36996432BFCDQ34323630-04C7FCDF-3F7C-49D9-B6C4-1D815913B432Q37116123-72C2007E-2D1F-448C-A99B-7C3F4581C7D2Q37360922-3D2606BD-142E-4101-9C69-AC615DCE1F5EQ37714256-E726025E-E967-481D-ACBB-90C85B89D7A2Q37828245-1C3010E0-3C70-4926-BC37-FF411D03AF07Q37970730-569207CE-9D8C-4DED-AD04-F2A3D0BB8484Q38167539-4547A158-E3B0-40D9-BE72-512BC46AA44BQ38187427-D2625F7E-D3AB-48E1-9BAB-66373A029077Q38573948-80FF4DE9-F82C-45C2-B791-5EEFF58ACFB8Q38619443-3C613A36-07B4-47D3-8E77-2B785ECCF54DQ38619498-2331A371-C56B-43A6-9774-32843E6E21F9Q38619552-F6790B18-19C0-44DF-9F57-22FB9D915A93Q38619585-E4C35D3D-8967-4442-AF48-6B40629DD0D3Q38954732-BF59B6F2-1FCC-4185-AEA3-800209AA9007Q42104105-BDCA08EF-B2D1-43BD-8249-F05E8FE16878Q43119931-7AF7D65E-148C-41A5-A226-DA81BE80A948Q43129049-1916031A-1450-40F5-A448-FDFE711DC732Q43148408-75064D1D-F057-4246-B490-A4A7F50E83ACQ43183776-E92B50B4-713D-4AF6-8F97-FED4DB13A98DQ43264321-FA323128-81B9-41C0-B163-8B78A3F08E6CQ43270859-F0D90A09-5458-4E5F-89A1-CCC42781DBA9Q43906519-7023CF51-CC08-4085-89A8-3A9DC1822993Q44037008-84EDDF00-3ADA-4C50-A7FC-AE86413146F7Q44100923-8ED66068-756C-4019-B537-A7C91F1D1E22Q44101060-DF45A497-665C-420B-90D8-C5A3819DC4E5Q44160637-B317BB36-6F72-4265-AC11-333957B725C1Q44193644-4F439B04-551F-4261-ACDC-A9651726D2E4Q44196270-8DFA5EE3-D19A-4FA3-9412-E7E700A06C5BQ44225174-E76D1D34-39E0-4A72-A4A2-A053314BCE3CQ44386485-9FD7F3B3-4324-4C1C-BE3B-91C576DAA42BQ44407100-BAFB790E-332E-40EC-B4D5-4319216FB99CQ44553826-BBB378CA-3067-4D43-9847-E02EEE1AB0D2Q44645227-E634AFCD-1BD1-4725-ACEA-51F3356DA9F4Q45990894-1E636FDC-6217-4BB7-9BB1-28DF14D19E02Q46050543-66EBED39-A9FF-43B7-96BB-C735B4914BF4
P50
description
researcher
@en
wetenschapper
@nl
name
R O Williams
@ast
R O Williams
@en
R O Williams
@nl
type
label
R O Williams
@ast
R O Williams
@en
R O Williams
@nl
prefLabel
R O Williams
@ast
R O Williams
@en
R O Williams
@nl
P106
P31
P496
0000-0003-4993-6427